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Somatostatin (somatotropin release-inhibiting hormone, SRIH)
was originally discovered (K r u l i c h et al., 1968) during puri-
fication of growth hormone-releasing hormone from rat hypo-
thalamus and was subsequently isolated and characterizated in
1972 from ovine hypothalamus (B r a z e a u et al., 1973). Two
active forms of SRIH were described: SRIH-28 and SRIH-14.
The neuropeptide somatostatin, widely expressed in both the
peripheral and the central nervous system (CNS) (R e i c h l i n,
1983), has multiple functions in higher organisms. It regulates
endocrine and exocrine secretion, possesses antiproliferative
properties, and acts as a neurotransmitter/neuromodulator (R e -
u b i, 1997). These diverse physiological effects are mediated by
a family of G-protein-coupled cell surface receptors, the soma-
tostatin receptors, named sstr1 to sstr5 (Ö s a p a y and Ö s a -
p a y, 1998). 
In view of the above, the purpose of this study was to ex-
amine the effects of administration of SRIH-14 on morpholog-
ical and stereological parameters of adrenocorticotropic
(ACTH) cells in neonatal female rats.
Time-mated pregnant Wistar rats were housed individually
and maintained in a controlled environment (12 h light: 12 h
dark; 22 ± 2°C), with food (product of Veterinarski zavod Sub-
otica, Subotica, Serbia) and water freely available. Female pups
were injected s.c. twice a day (8 am and 8 pm) with 20 mg of
SRIH-14 (S9129, Sigma, St. Louis, Mo., USA) per 100 g b.w.
for five consecutive days starting from the 3rd to 7th day of life
(the first group). Female pups of the second group served as the
control, and received physiological saline. All animals were
sacrificed by decapitation under deep anesthesia 12 h after the
last treatment. Experimental protocols were approved by the
Local Animal Care Committee and conformed to the recom-
mendations given in “Guide for the Care and Use of Laborato-
ry Animals” (1996, National Academy Press, Washington D.
C.). Pituitary glands were excised, fixed in Bouin’s solution and
embedded in paraffin. Serial tissue sections 5 mm thick were de-
paraffinized. Pituitary ACTH cells were localized by the perox-
idase-antiperoxidase-complex (PAP) method of Sternberger  et
al. (1970). Measurements were performed on the widest portion
of the pituitary gland and immunocytochemically-labelled
ACTH cells were analyzed by the M42 test system. For calcula-
tions of cell and nuclear volumes, the formula of We i b e l
(1979) was used. Morphometric data obtained from each rat
were averaged per experimental group and the standard devia-
tion of the mean (SD) was calculated.  The Student t-test was
used to evaluate differences between the two groups and a prob-
ability value of 5% or less was considered statistically signifi-
cant.
Data on body weight and absolute and relative weight of
the pituitary in the SRIH-treated and control groups are summa-
rized in Table 1. As can be seen, body weight and absolute and
relative pituitary weights were not significantly (p>0.05)
changed in SRIH-treated animals compared with the controls.
ACTH-immunoreactive cells of control neonatal female rat pi-
tuitaries were stellate in shape with the cytoplasmatic processes
among neighboring cells and localization between the capilla-
ries. The nucleus followed the shape of the cell body. Small,
specific secretory granules were distributed mainly on the pe-
riphery of the cytoplasm (Fig. 1a). In SRIH-treated rats, these
cells were smaller, irregularly shaped, with more intensely
stained secretory granules (Fig. 1b). All morphometric parame-
ters were decreased in both SRIH-treated groups compared to
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Table 1. Effects of SRIH-14 on body weight and absolute and relative
pituitary weight in neonatal female rats. Values are means ± S.D. (n =
5).
 





Control 17.8 ± 0.7 2.0 ± 1.0 11.2 ± 5.4 
SRIH-14 16.1 ± 1.8 (-10%) 
1.8 ± 0.8 
(-10%) 
11.6 ± 5.3 
(+4%) 
 
Table 2. Morphometic parameters  of ACTH cells in female rats after
neonatal treatment with SRIF-14. Values are means ± S.D. (n = 5), * p
< 0.05.
 
Groups Volume of ACTH cells (µm³) 
Volume of ACTH nuclei 
(µm³) 
Relative volumetric 
density of ACTH cells 
(%) 
Control 1242 ± 25.5 137.5 ± 3.5 16.5 ± 2.2 
SRIH-14 757.0 ± 45.2* (- 39 %) 
115.0 ± 14.1* 
(- 16 %) 




saline-treated rats (Table 2). The volume of ACTH cells and
their nuclei were significantly decreased (p<0.05) by 39% and
16%, respectively, in comparison with the corresponding con-
trols. The volumetric density of ACTH cells in neonatally treat-
ed rats was significantly decreased (p<0.05) by 33% in compar-
ison with the controls (Table 2). 
The obtained results demonstrate that SRIH-14, applied
multiply in the neonatal period, exerted an inhibitory influence
on ACTH cell morphology in neonatal female rats. These data
are in accordance with our previous observation (S t a r č e v i ć
et al. 2000) that intracerebroventricular (i.c.v.) administration of
SRIH-28 to rat females exerts significant inhibitory action on
the function and morphometric charateristics of ACTH cells.
Moreover, Octreotide applied i.c.v. exerts significant inhibitory
effects on the immunohistochemical and morphometric charac-
teristics of ACTH cells in both female and male rats (M i l o š -
e v i ć et al. 2001, 2003). The mechanism of inhibition of
ACTH secretion may be through inhibition of CRF release from
the hypothalamus (S h i b a s a k i et al., 1988). L i t v i n et al.
(1986) asserted that SRIH inhibits CRF-induced ACTH secre-
tion from At20 cells in vitro. The action of SRIH is dose-de-
pendent with a half-maximal effect at 1 x 10-9 M and results in
decreased maximal ACTH secretion (R i c h a r d s o n, 1983).
In conclusion, systemic application of SRIH-14 by the s.c.
route produced a marked decrease in stereological parameters
of the pituitary ACTH cells. 
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Fig. 1. Imunohistochemically labelled ACTH cells in: a) control rats,
b) SRIH-14 treated females (PAP, 1256 X).
